Albemarle Corporation $ALB Stock: Russell Investments Group Ltd. Decreases Holdings

Russell Investments Group Ltd. trimmed its holdings in Albemarle Corporation (NYSE:ALB – Free Report) by 32.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 223,098 shares of the specialty chemicals company’s stock after selling 109,060 shares during the quarter. Russell Investments Group Ltd. owned 0.19% of Albemarle worth $23,601,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Primecap Management Co. CA purchased a new position in shares of Albemarle during the 2nd quarter valued at about $358,101,000. Deutsche Bank AG acquired a new position in shares of Albemarle in the 2nd quarter valued at about $131,049,000. Bank of New York Mellon Corp purchased a new stake in shares of Albemarle in the second quarter worth about $103,268,000. Robeco Institutional Asset Management B.V. boosted its stake in shares of Albemarle by 2,981.1% in the third quarter. Robeco Institutional Asset Management B.V. now owns 733,793 shares of the specialty chemicals company’s stock worth $77,621,000 after buying an additional 709,977 shares during the last quarter. Finally, ProShare Advisors LLC boosted its stake in shares of Albemarle by 69.7% in the third quarter. ProShare Advisors LLC now owns 1,436,117 shares of the specialty chemicals company’s stock worth $151,912,000 after buying an additional 589,787 shares during the last quarter. 92.87% of the stock is owned by hedge funds and other institutional investors.

Albemarle Trading Down 0.6%

Shares of Albemarle stock opened at $87.67 on Wednesday. The firm has a 50-day simple moving average of $102.00 and a two-hundred day simple moving average of $144.61. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 2.34. Albemarle Corporation has a fifty-two week low of $87.26 and a fifty-two week high of $221.00. The company has a market cap of $10.35 billion, a P/E ratio of 21.18, a price-to-earnings-growth ratio of 0.55 and a beta of 1.34.

Albemarle (NYSE:ALB – Get Free Report) last posted its earnings results on Wednesday, November 4th. The specialty chemicals company reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.05. Albemarle had a return on equity of 14.91% and a net margin of 10.40%. The firm had revenue of $1.55 billion for the quarter, compared to analysts’ expectations of $1.52 billion. During the same period last year, the firm earned ($0.19) EPS. The company’s quarterly revenue was up 18.8% on a year-over-year basis. As a group, equities analysts predict that Albemarle Corporation will post 10.64 earnings per share for the current fiscal year.

Albemarle Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, December 18th will be given a dividend of $0.41 per share. The ex-dividend date is Friday, December 18th. This represents a $1.64 dividend on an annualized basis and a yield of 1.9%. Albemarle’s dividend payout ratio is currently 39.61%.

Wall Street Analyst Weigh In

ALB has been the topic of several analyst reports. Rothschild & Co Redburn dropped their target price on Albemarle from $100.00 to $86.00 in a report on Wednesday, November 11th. Weiss Ratings raised Albemarle from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, November 4th. JPMorgan Chase & Co. lowered their price objective on Albemarle from $160.00 to $140.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 25th. Wall Street Zen lowered Albemarle from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. Finally, BMO Capital Markets dropped their price objective on shares of Albemarle from $200.00 to $175.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 6th. Fifteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $152.63.

Get Our Latest Analysis on ALB

Albemarle Profile

(Free Report)

Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.

Further Reading

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB – Free Report).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.